Rethinking early bone-loss treatment.
D019386:Alendronate / Q000627:therapeutic use*; D001851:Bone Diseases, Metabolic / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans
D019386:Alendronate